3-Jahres-Update zur Therapie mit Tebentafusp beim metastasierten Uveamelanom
J Dtsch Dermatol Ges
.
2024 Mar;22(3):485-487.
doi: 10.1111/ddg.15391_g.
[Article in German]
Authors
Jessica C Hassel
,
Carola Berking
PMID:
38450999
DOI:
10.1111/ddg.15391_g
No abstract available
MeSH terms
Humans
Melanoma*
Neoplasms, Second Primary*
Recombinant Fusion Proteins*
Uveal Neoplasms*
Substances
tebentafusp
Recombinant Fusion Proteins
Supplementary concepts
Uveal melanoma